Invention Grant
- Patent Title: Enhanced brain bioavailability of galantamine by selected formulations and transmucosal administration of lipophilic prodrugs
-
Application No.: US16287413Application Date: 2019-02-27
-
Publication No.: US11077119B2Publication Date: 2021-08-03
- Inventor: Alfred Maelicke
- Applicant: Neurodyn Life Sciences Inc.
- Applicant Address: CA Charlottetown
- Assignee: Neurodyn Life Sciences Inc.
- Current Assignee: Neurodyn Life Sciences Inc.
- Current Assignee Address: CA Charlottetown
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: EP12178187 20120727
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K9/14 ; A61K31/00 ; A61K9/20 ; A61K9/28 ; A61K9/107 ; A61K9/00
Abstract:
A method of treating a subject for a brain disease associated with cognitive impairment, including administering to a subject a chemical substance according to GLN-1062 or salt thereof: wherein the treatment includes transmucosal administration of a therapeutically effective amount of GLN 1062 or salt thereof in the oral cavity of the subject.
Public/Granted literature
Information query
